Mr. Mike Withrow reports

AREV NANOTEC BRANDS INC. ANNOUNCES CLOSING OF THEIR NON-BROKERED PRIVATE PLACEMENT

Arev Nanotec Brands Inc. has closed $670,000 of the previously announced $725,000 private placement. The non-brokered private placement was for up to 2.68 million units of the company at a price of 25 cents per unit for gross proceeds of $670,000. Each unit will consist of one common share and one common share purchase warrant. Each whole warrant entitles the holder thereof to purchase one additional common share of the company at a price of 28 cents per share at any time on or before 5 p.m. Vancouver time on the date that is 24 months from the date of issuance of the warrants, except that, if over a period of 10 consecutive trading days between the date that is four months and a day from the date of issuance of the warrants and the date that the warrants would otherwise expire, the closing price of the company's common shares on the Canadian Securities Exchange (or such other stock exchange where the majority of the trading volume for the company's common shares occurs) is at or exceeds 75 cents, then the company may, at its option, provide written notice to the warrantholders to exercise their warrants within 30 days of the date of the notice, failing which the warrants will expire.

Securities issued by the company pursuant to the financing will be subject to a four-month-and-one-day hold period in Canada commencing on the closing date. The net proceeds from the financing will be used for general working capital, product development and distribution purposes. An insider has subscribed for 400,000 units of this financing.

The company has decided not to proceed with the balance of the previously announced $725,000 private placement, a total of $55,000, as it believes that it can create greater shareholder value by financing at higher prices in the future and that the proceeds raised to date will be sufficient working capital for the company's immediate needs. This placement was concluded with strategic investors.

About Arev Nanotec Brands Inc.

Arev produces phytomedicinal extracts through its proprietary state-of-the-art extraction methodologies for the life science industry. The Arev model is to advance extraction technologies that provide opportunities for next-generation phytomedicine. Arev Nanotec is a member of BIO, the world's largest trade association, representing biotechnology companies, academic institutions, state biotechnology centres, and related organizations across the United States and in more than 30 other countries.

We seek Safe Harbor.